202 related articles for article (PubMed ID: 23298489)
1. YES-associated protein 1 promotes adenocarcinoma growth and metastasis through activation of the receptor tyrosine kinase Axl.
Cui ZL; Han FF; Peng XH; Chen X; Luan CY; Han RC; Xu WG; Guo XJ
Int J Immunopathol Pharmacol; 2012; 25(4):989-1001. PubMed ID: 23298489
[TBL] [Abstract][Full Text] [Related]
2. Yes-associated protein 1 (YAP1) promotes human gallbladder tumor growth via activation of the AXL/MAPK pathway.
Li M; Lu J; Zhang F; Li H; Zhang B; Wu X; Tan Z; Zhang L; Gao G; Mu J; Shu Y; Bao R; Ding Q; Wu W; Dong P; Gu J; Liu Y
Cancer Lett; 2014 Dec; 355(2):201-9. PubMed ID: 25218593
[TBL] [Abstract][Full Text] [Related]
3. Expression of Yes-associated protein in gastric adenocarcinoma and inhibitory effects of its knockdown on gastric cancer cell proliferation and metastasis.
Zhang J; Xu ZP; Yang YC; Zhu JS; Zhou Z; Chen WX
Int J Immunopathol Pharmacol; 2012; 25(3):583-90. PubMed ID: 23058008
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of AXL receptor tyrosine kinase in osteosarcoma cells leads to decreased proliferation and increased apoptosis.
Zhang Y; Tang YJ; Man Y; Pan F; Li ZH; Jia LS
Int J Immunopathol Pharmacol; 2013; 26(1):179-88. PubMed ID: 23527720
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic characteristics of YES-associated protein 1 overexpression and its relationship to tumor biomarkers in gastric cancer.
Zhang J; Yang YC; Zhu JS; Zhou Z; Chen WX
Int J Immunopathol Pharmacol; 2012; 25(4):977-87. PubMed ID: 23298488
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of MMP12 inhibits the growth and invasion of lung adenocarcinoma cells.
Lv FZ; Wang JL; Wu Y; Chen HF; Shen XY
Int J Immunopathol Pharmacol; 2015 Mar; 28(1):77-84. PubMed ID: 25816409
[TBL] [Abstract][Full Text] [Related]
7. Association between AXL, Hippo Transducers, and Survival Outcomes in Male Breast Cancer.
Di Benedetto A; Mottolese M; Sperati F; Ercolani C; Di Lauro L; Pizzuti L; Vici P; Terrenato I; Shaaban AM; Humphries MP; Sundara-Rajan S; Barba M; Speirs V; De Maria R; Maugeri-Saccà M
J Cell Physiol; 2017 Aug; 232(8):2246-2252. PubMed ID: 27987320
[TBL] [Abstract][Full Text] [Related]
8. The role and clinical significance of YES-associated protein 1 in human osteosarcoma.
Zhang YH; Li B; Shen L; Shen Y; Chen XD
Int J Immunopathol Pharmacol; 2013; 26(1):157-67. PubMed ID: 23527718
[TBL] [Abstract][Full Text] [Related]
9. COPB2 promotes cell proliferation and tumorigenesis through up-regulating YAP1 expression in lung adenocarcinoma cells.
Pu X; Wang J; Li W; Fan W; Wang L; Mao Y; Yang S; Liu S; Xu J; Lv Z; Xu L; Shu Y
Biomed Pharmacother; 2018 Jul; 103():373-380. PubMed ID: 29674272
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of the inflammatory factor pentraxin-3 suppresses growth and invasion of lung adenocarcinoma through the AKT and NF-kappa B pathways.
Hu FQ; Qiao T; Xie X; Hu R; Xiao HB
J Biol Regul Homeost Agents; 2014; 28(4):649-57. PubMed ID: 25620175
[TBL] [Abstract][Full Text] [Related]
11. Axl gene knockdown inhibits the metastasis properties of hepatocellular carcinoma via PI3K/Akt-PAK1 signal pathway.
Xu J; Jia L; Ma H; Li Y; Ma Z; Zhao Y
Tumour Biol; 2014 Apr; 35(4):3809-17. PubMed ID: 24347489
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of MMP11 inhibits proliferation and invasion of gastric cancer cells.
Kou YB; Zhang SY; Zhao BL; Ding R; Liu H; Li S
Int J Immunopathol Pharmacol; 2013; 26(2):361-70. PubMed ID: 23755751
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF-κB pathway in vitro and in vivo.
Zhang J; Kou YB; Zhu JS; Chen WX; Li S
Int J Oncol; 2014 Apr; 44(4):1268-76. PubMed ID: 24481712
[TBL] [Abstract][Full Text] [Related]
14. The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target.
Koorstra JB; Karikari CA; Feldmann G; Bisht S; Rojas PL; Offerhaus GJ; Alvarez H; Maitra A
Cancer Biol Ther; 2009 Apr; 8(7):618-26. PubMed ID: 19252414
[TBL] [Abstract][Full Text] [Related]
15. 17-AAG suppresses growth and invasion of lung adenocarcinoma cells via regulation of the LATS1/YAP pathway.
Ye XY; Luo QQ; Xu YH; Tang NW; Niu XM; Li ZM; Shen SP; Lu S; Chen ZW
J Cell Mol Med; 2015 Mar; 19(3):651-63. PubMed ID: 25712415
[TBL] [Abstract][Full Text] [Related]
16. AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma.
Xu MZ; Chan SW; Liu AM; Wong KF; Fan ST; Chen J; Poon RT; Zender L; Lowe SW; Hong W; Luk JM
Oncogene; 2011 Mar; 30(10):1229-40. PubMed ID: 21076472
[TBL] [Abstract][Full Text] [Related]
17. Activation of AXL and antitumor effects of a monoclonal antibody to AXL in lung adenocarcinoma.
Iida S; Miki Y; Suzuki T; Mori K; Saito M; Niikawa H; Kondo T; Yamada-Okabe H; Sasano H
Anticancer Res; 2014 Apr; 34(4):1821-7. PubMed ID: 24692715
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma.
Song X; Wang H; Logsdon CD; Rashid A; Fleming JB; Abbruzzese JL; Gomez HF; Evans DB; Wang H
Cancer; 2011 Feb; 117(4):734-43. PubMed ID: 20922806
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of PTTG1 inhibits the growth and invasion of lung adenocarcinoma cells through regulation of TGFB1/SMAD3 signaling.
Li WH; Chang L; Xia YX; Wang L; Liu YY; Wang YH; Jiang Z; Xiao J; Wang ZR
Int J Immunopathol Pharmacol; 2015 Mar; 28(1):45-52. PubMed ID: 25816405
[TBL] [Abstract][Full Text] [Related]
20. AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer.
Dunne PD; McArt DG; Blayney JK; Kalimutho M; Greer S; Wang T; Srivastava S; Ong CW; Arthur K; Loughrey M; Redmond K; Longley DB; Salto-Tellez M; Johnston PG; Van Schaeybroeck S
Clin Cancer Res; 2014 Jan; 20(1):164-75. PubMed ID: 24170546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]